Symposium overview: Estrogens and antiestrogens in managing the patient with breast cancer

Lisa A. Newman, William C. Wood, Rena V. Sellin, Monica Morrow, Charles Vogel, S. Eva Singletary

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The prevalence of breast cancer (a hormonally driven neoplasm) in the United States, the potential health benefits of estrogen replacement therapy for postmenopausal women, and the burgeoning research focusing on selective estrogen receptor modulators (SERMs) have resulted in additional complexity in managing breast cancer. In an attempt to clarify existing data, the Society of Surgical Oncology sponsored a symposium entitled 'Estrogens and Antiestrogens in Managing the Patient with Breast Cancer' at its 52nd Annual Cancer Symposium. This conference was held in March 1999 and was chaired by Dr. S. Eva Singletary, Professor of Surgery and Chief of the Surgical Breast Section at The University of Texas M. D. Anderson Cancer Center in Houston, Texas. The following is a review of the material presented by the symposium participants.

Original languageEnglish
Pages (from-to)568-574
Number of pages7
JournalAnnals of Surgical Oncology
Volume7
Issue number8
StatePublished - Oct 2 2000
Externally publishedYes

Fingerprint

Estrogen Receptor Modulators
Estrogens
Breast Neoplasms
Selective Estrogen Receptor Modulators
Neoplasms
Estrogen Replacement Therapy
Insurance Benefits
Breast
Research

Keywords

  • Antiestrogen
  • Breast cancer

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Newman, L. A., Wood, W. C., Sellin, R. V., Morrow, M., Vogel, C., & Singletary, S. E. (2000). Symposium overview: Estrogens and antiestrogens in managing the patient with breast cancer. Annals of Surgical Oncology, 7(8), 568-574.

Symposium overview : Estrogens and antiestrogens in managing the patient with breast cancer. / Newman, Lisa A.; Wood, William C.; Sellin, Rena V.; Morrow, Monica; Vogel, Charles; Singletary, S. Eva.

In: Annals of Surgical Oncology, Vol. 7, No. 8, 02.10.2000, p. 568-574.

Research output: Contribution to journalArticle

Newman, LA, Wood, WC, Sellin, RV, Morrow, M, Vogel, C & Singletary, SE 2000, 'Symposium overview: Estrogens and antiestrogens in managing the patient with breast cancer', Annals of Surgical Oncology, vol. 7, no. 8, pp. 568-574.
Newman LA, Wood WC, Sellin RV, Morrow M, Vogel C, Singletary SE. Symposium overview: Estrogens and antiestrogens in managing the patient with breast cancer. Annals of Surgical Oncology. 2000 Oct 2;7(8):568-574.
Newman, Lisa A. ; Wood, William C. ; Sellin, Rena V. ; Morrow, Monica ; Vogel, Charles ; Singletary, S. Eva. / Symposium overview : Estrogens and antiestrogens in managing the patient with breast cancer. In: Annals of Surgical Oncology. 2000 ; Vol. 7, No. 8. pp. 568-574.
@article{9f84f57a61d44266ad0235d8885498ee,
title = "Symposium overview: Estrogens and antiestrogens in managing the patient with breast cancer",
abstract = "The prevalence of breast cancer (a hormonally driven neoplasm) in the United States, the potential health benefits of estrogen replacement therapy for postmenopausal women, and the burgeoning research focusing on selective estrogen receptor modulators (SERMs) have resulted in additional complexity in managing breast cancer. In an attempt to clarify existing data, the Society of Surgical Oncology sponsored a symposium entitled 'Estrogens and Antiestrogens in Managing the Patient with Breast Cancer' at its 52nd Annual Cancer Symposium. This conference was held in March 1999 and was chaired by Dr. S. Eva Singletary, Professor of Surgery and Chief of the Surgical Breast Section at The University of Texas M. D. Anderson Cancer Center in Houston, Texas. The following is a review of the material presented by the symposium participants.",
keywords = "Antiestrogen, Breast cancer",
author = "Newman, {Lisa A.} and Wood, {William C.} and Sellin, {Rena V.} and Monica Morrow and Charles Vogel and Singletary, {S. Eva}",
year = "2000",
month = "10",
day = "2",
language = "English",
volume = "7",
pages = "568--574",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Symposium overview

T2 - Estrogens and antiestrogens in managing the patient with breast cancer

AU - Newman, Lisa A.

AU - Wood, William C.

AU - Sellin, Rena V.

AU - Morrow, Monica

AU - Vogel, Charles

AU - Singletary, S. Eva

PY - 2000/10/2

Y1 - 2000/10/2

N2 - The prevalence of breast cancer (a hormonally driven neoplasm) in the United States, the potential health benefits of estrogen replacement therapy for postmenopausal women, and the burgeoning research focusing on selective estrogen receptor modulators (SERMs) have resulted in additional complexity in managing breast cancer. In an attempt to clarify existing data, the Society of Surgical Oncology sponsored a symposium entitled 'Estrogens and Antiestrogens in Managing the Patient with Breast Cancer' at its 52nd Annual Cancer Symposium. This conference was held in March 1999 and was chaired by Dr. S. Eva Singletary, Professor of Surgery and Chief of the Surgical Breast Section at The University of Texas M. D. Anderson Cancer Center in Houston, Texas. The following is a review of the material presented by the symposium participants.

AB - The prevalence of breast cancer (a hormonally driven neoplasm) in the United States, the potential health benefits of estrogen replacement therapy for postmenopausal women, and the burgeoning research focusing on selective estrogen receptor modulators (SERMs) have resulted in additional complexity in managing breast cancer. In an attempt to clarify existing data, the Society of Surgical Oncology sponsored a symposium entitled 'Estrogens and Antiestrogens in Managing the Patient with Breast Cancer' at its 52nd Annual Cancer Symposium. This conference was held in March 1999 and was chaired by Dr. S. Eva Singletary, Professor of Surgery and Chief of the Surgical Breast Section at The University of Texas M. D. Anderson Cancer Center in Houston, Texas. The following is a review of the material presented by the symposium participants.

KW - Antiestrogen

KW - Breast cancer

UR - http://www.scopus.com/inward/record.url?scp=0033834990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033834990&partnerID=8YFLogxK

M3 - Article

C2 - 11005554

AN - SCOPUS:0033834990

VL - 7

SP - 568

EP - 574

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 8

ER -